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Background. Over time, the striae rubra develop into striae alba that appear white, ﬂat, and depressed. It is very important to
determine the optimum striae management. In order to evaluate the eﬀectiveness of these therapies, objective measurement tools
are necessary. Objective. The aim of this study is to evaluate if ultrasonography and PRIMOS can be used to obtain an objective
assessment of stretch marks type and stage; furthermore, we aim to apply these techniques to evaluate the eﬃcacy of a topical
treatment. Methods. 20 volunteers were enrolled with a two-month study. A marketed cosmetic product was used as the active over
one body area. The controlateral area with stretch marks was treated with a “placebo” formulation without active, as a control.
The instrumental evaluation was carried out at the beginning of the trial (baseline values or t0), after 1 month (t1), and at the
end of the study (t2). Results. PRIMOS was able to measure and document striae distensae maturation; furthermore, ultrasound
imaging permitted to visualize and diagnose the striae. Statistical analysis of skin roughness demonstrated a statistically signiﬁcant
reduction of Rp value only in a treated group. In fact, the Rp value represented a maximum peak height in the area selected. These
results demonstrated that after two months of treatment only the striae rubra can be treated successfully. Conclusions. This work
demonstratedthatthe22MHzultrasoundcandiagnosestretchmarks;PRIMOSdevicecandetectandmeasurestriaedistensaetype
and maturation. Furthermore, the high-frequency ultrasound and the 3D image device, described in this work, can be successfully
employed in order to evaluate the eﬃcacy of a topical treatment.
1.Introduction
StriaeDistensaeorstretchmarks(SDs)areawell-recognized,
common skin condition that rarely causes some signiﬁcant
medical problems but is often a signiﬁcant source of distress
for those aﬀected [1]. SDs arise from progressive or rapid
stretching of the dermis (1) and appear along cleavage
lines perpendicular to the direction of greatest tension in
areas with the most adipose tissue [2, 3]. The classic ana-
tomical sites aﬀected include the abdomen and breasts for
pregnancy-related striae, the outer thighs or lumbosacral
regions in adolescent boys, and the buttocks, thighs, upper
arms, and breasts in adolescent girls [2, 4]. Causes of SD are
not clear, and a number of theories have been proposed.
Many authors had shown that mechanical eﬀect of
stretching is the main cause, leading to the rupture of the
connectivetissueframework(e.g.,pregnancy,obesity,weight
lifting) [5, 6]. Osman has denounced this theory, not ﬁnding
any relationship between growth in abdominal girth in
pregnant women and formation of SD [7]. Normal growth
has been suggested as another cause, with these marks com-
monly developing during adolescence and associated with
the rapid increase in size of particular regions of the body
[8]. Similarly, obesity and rapid changes in weight have
been shown to be associated with the development of SD.
Moreover, Kogoj anticipated a damage of the tissues by a
toxic way, resulting in striations [9]. Others suggested that
SDs are a feature of high serum levels of steroid hormones
induced from local or systemic steroid therapy or Cushing’s
disease. High steroid hormone levels have a catabolic eﬀect
on the activity of ﬁbroblasts and decrease the deposition of
collagen in the dermal matrix substance [10, 11]. SDs have
been reported in patients with chronic liver disease, HIV,
cachetic states, and anorexia nervosa [12–15].
Striae progress through three diﬀerent stages of matu-
ration: the acute stage is characterized by red and slightly2 Dermatology Research and Practice
raised striae (rubra), the subacute stage is characterized by
purpuric striae, and the chronic stage is characterized by
hypopigmented and atrophic striae (alba) [16]. In particular,
striae rubra are ﬂattened areas of skin with a pink-red
hue that may be itchy and slightly raised. Then they are
predisposed to increase in length and to acquire a darker
purple color. Over time, the striae rubra develop into striae
alba that appear white, ﬂat, and depressed [17, 18]. Striae
are separated from normal skin by a densely packed area
of thin, eosinophilic collagen bundles, horizontal to the
surface in a parallel orientation. Striae lack rete pegs, adnexal
structures, and normal dermal undulations. In addition, hair
follicles and other appendages are absent. Dermoscopy and
histology studies have demonstrated that the color variations
of striae are inﬂuenced by melanocyte mechanobiology and
that striae formation occurs parallel to the wound-healing
process of regular scar formation [16, 18]. Histologically,
initial inﬂammatory changes are followed by a ﬂattening and
thinning of the epidermis due to underlying changes in the
numbers and organization of collagen, ﬁbrillin, and elastin
ﬁbers. Histological studies of mature striae reveal stretched
collagen ﬁbers aligned parallel to the skin surface, followed
by subsequent loss of collagen and increased ﬂattening of
rete ridges. Reduced amounts of ﬁbrillin surrounding the
dermal-epidermal junction (DE), reduced elastin in the pap-
illarydermis,andreorganizationofelastinandﬁbrillinﬁbers
in deep dermis contribute to the atrophied appearance of
striae [17, 19].
In order to improve stretch marks quality, multiple ther-
apies are under development. Treatment of striae varies and
includes topical tretinoin, hydrant creams, topical oil mas-
sage, glycolic acid, and trichloroacetic acid [20–26]. Newer
treatmentsinvolvelasers,includingthe308nmexcimerlaser,
intensed pulsed light, and 585nm ﬂash-lamped laser [2, 17,
27–29].
It is important that these therapies are evaluated in clin-
ical trials to determine the optimum SD management. In
o r d e rt oe v a l u a t et h ee ﬀectiveness of these therapies, objec-
tive measurement tools are necessary.
Especially in clinical trials, objective evaluation is more
reliable than subjective evaluation. In this direction, high-
frequency ultrasound and surface roughness evaluation can
be used together to the evaluation of SD improvement after
treatment.
Initially ultrasonography was utilized to depict normal
skin in a rapid and noninvasive way as cross-section images,
especially for the measurement of skin thickness. Apart from
the measurement of skin thickness, the main indications
for ultrasonography in dermatology are the monitoring of
the course and therapeutic eﬃcacy of the disease treatment
with skin sclerosis (e.g., morphea, systemic scleroderma,
scleroderma like diseases) and the studies on the eﬀects of
topical and systemic drugs on the skin [30].
Currently, the evaluation of microrelief roughness and
their modiﬁcation is often only evaluated subjectively by
means of a scale (Fitzpatrick skin type for striae distensae).
But, several objective measurement tools for skin surface
roughness can be distinguished. The majority of these tools
use a silicone replica of the skin, after which the topography
of the replica is measured. This indirect measurement is
performed by use of mechanical, optical, laser, transparency
or interference fringe projection proﬁlometry [31–36]. The
use of replicas is time-consuming and, therefore, not feasible
in an outpatient setting. In addition, air bubbles, gravity,
and patient movement may have an eﬀect on the quality of
the replica [37]. Another measurement method is the use
of skin biopsy specimens but this technique is invasive [38].
In the last years, the use of a measuring device (PRIMOS)
has permitted the in vivo evaluation of human skin surface
topography that represents the three-dimensional (3D)
organization of the dermis and the subcutaneous tissue.
The surface topography can be considered a mirror of the
functional status of the skin. In order to assess the success
of an SD therapy the depth, variation and distribution of
the furrows need to be measured prior and after treatment.
Several articles have reported on the use of this instrument.
First of all, the PRIMOS has been used in the cosmetic
industry to measure human skin topography and volume of
wrinkles. In addition, it has been used to objectively evaluate
the depths of acne scars. Roques et al. successfully tested
the PRIMOS in two patients with scars and recommended
further testing of this assessment tool [39, 40].
The aim of this study is to evaluate if ultrasonography
and PRIMOS can be used to obtain an objective assessment
ofstretchmarkstypeandstage;furthermore,weaimtoapply
these techniques to evaluate the eﬃcacy of topical treatment.
2.MaterialsandMethods
2.1. In Vivo Study Design. The study has been carried out
according to Helsinki declaration (Ethical Principles for
Medical Research Involving Human Subjects). Twenty
healthy volunteers, of both sex, between 22 and 38 years old,
showing stretch marks on buttocks, lateral abdomen, breast,
and internal and external thights were selected according to
the following inclusion criteria: people who have striae rubra
and/or striae alba, good general health; absence of cutaneous
diseases; and people who do not show pigmentary lesions or
other lesions on the interest area that could interfere with the
evaluation study.
Volunteers were enrolled with a two-month study. A
marketed cosmetic product was used as the active which
was applied once daily by massage over one body area.
The controlateral area with stretch marks was treated with
a “placebo” formulation without active, as a control. The
instrumental evaluation was carried out at the beginning of
the trial (baseline values or t0), after 1 month (t1), and at the
end of the study (t2).
Allmeasurementsweremadeinanair-conditionedroom
with controlled temperature and humidity (T 22◦C, r.h. 50±
5%); subjects were preconditioned for at least 15 minutes
before the measurements.
2.2. High-Frequency Ultrasound Scanning. The high-fre-
quency scanners available today operate at frequencies
between 20MHz and 1-2GHz. The optimal frequency range
for dermatological questions is between 20 and 100MHz
[41].Dermatology Research and Practice 3
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Figure 1: Schematic representation of steps used to produce two-dimensional sonographic cross-section of skin [42].
Using a 20MHz transducer it is possible to visualize
structures up to 6-7mm in depth. This means that the zones
of diagnostic interest are covered, that is, epidermis, corium,
and one portion of subcutaneous fatty tissue. Particularly,
if the subcutis is not very well developed, evaluation of the
muscle fasciae is also possible.
The main modes of scanning in commercial available
trasducers are the A-scan and B-mode. In A-scan the am-
plitude scan maps the intensity of reﬂections encountered
along a single line through the skin surface. The result is
displayed in a graph that plots amplitude of each reﬂection
by the reﬂection’s depth and this mode can be used to assess
skin thickness. In a B-mode the brightness display collects
data from many individual A-scan soundings and presents
it in a digitalized two-dimensional picture in which bright
pixels represent strong reﬂections and dark pixels depict the
absence of reﬂections (Figure 1).
With trasducers of 20MHz the dermis appears echogenic
with echoes originating from the ﬁber network comprised of
collagen and elastic ﬁbers; tissue atrophy and edema appear
as echo-poor areas. Several skin diseases are characterized by
changes both in the epidermis and in the dermis. Ultrasound
scanning can be used in dermatological ﬁeld to assess skin
thickness, tissue edema, inﬂammatory conditions, and the
extent of dermal and subcutaneous ﬁbrosis as well as to
monitor the course of wound healing [43–45].
In our work a 22MHz ultrasound device DUB-system
(tpm-Taberna pro medicum, Luneburg, DE), 72µmr e s o l u -
tion, 7-8mm penetration, was used; the B-mode and A-scan
were used, respectively, to acquire skin images and to obtain
measurements of skin tissues thickness.
2.3. 3D Imaging of the Skin. In this study, the in vivo Mea-
surement of the Skin (PRIMOSpico) (GFMesstechnik GmbH,
Teltow, Germany) was used to assess surface roughness of
normal skin and striae.
Three-dimensional (3D) imaging is a recent measuring
method in medicine. It uses optical projections, a high-
resolution video camera, and computer software to rapidly
generate images and measurements of skin topography.
The method has been used successfully in wound care;
dermatological laser treatments and its fundamental physics
have been validated. The skin surface structure can be
analyzed in the noncontact mode using the 3D optical sys-
tem, as described in detail by Jacobi et al. [40]. This system
is based on the digital stripe projection technique, which is
used as an optical measurement process. A parallel stripe
patternisprojectedontotheskinsurfaceanddepictedonthe
CCD (charged-coupled device) chip of a camera through an
optical system. The measurement system consists of a freely
movable optical measurement head (with an integrated
micromirror projector, a projection lens system, and a CCD
recording camera), together with an evaluation computer
(Figure 2). The 3D eﬀect is achieved by the minute elevation
diﬀerences on the skin surface, which deﬂect the parallel
projection stripes. The measurements of these deﬂections
represent qualitative and quantitative measurements of the
skin proﬁle.
We investigate both area treated with active and area
treated with “placebo” at diﬀerent times. The Primos system
allowed us to evaluate, by matching, the same skin area in
the three subsequent analysis times. After the measurements,
3-dimensional surface proﬁles were evaluated with the PRI-
MOS software. The 3D image acquired with the instrument
can be transformed by the Primos 5.7 software to obtain a
colored image in which each shade of color is related to a
height (Figure 2).
The instrument also determines the roughness, which
is based on the depth and the density of the skin furrows.4 Dermatology Research and Practice
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Figure 2: Principle of in vivo measurement of the skin.
Table 1: Mean values and standard deviation of skin roughness of striae treated with Active (A) or Placebo (Pl) product.
Pl-t0 µm( S D ) P l - t1 µm( S D ) P l - t2 µm( S D ) A - t0 µm( S D ) A - t1 µm( S D ) A - t2 µm( S D )
Rp 85.8 (20.75) 80.63 (14.71) 81.45 (17.68) 92.3 (22.04) 78.5 (26.69) 73.05 (16.29)
Rv 71.35 (15.57) 66.94 (14.81) 67.05 (16.52) 74.8 (17.05) 66.45 (17.03) 66 (13.80)
Calculation of surface roughness was carried out within an
area of 38.90 by 28.86mm.
After ﬁltering the photograph for hairs and the mac-
rocurvature of body parts, the surface roughness was pre-
sented in numerous parameters. Preliminary research of
these roughness parameters is maximum peak height (Rp)
and maximum valley depth (Rv).
2.4. Statistical Analysis. In order to compare baseline values
forskin thickness andskin roughnessbetween theActiveand
Placebo areas, the Mann-Whitney nonparametric test was
employed.One-wayanalysisofVariance(1wayANOVA)test
was used to compare skin values of all subjects at baseline,
after 1 month of application, and at the end of the study.
AllstatisticalanalyseswereperformedusingGraphPadPrism
software, version 5.0.
3. Results
3.1. Characterization Striae Type. The Primos Pico allowed
us to obtain a colored images in which each shade of color is
relatedtoaheight.Infact,thestriaerubraappearedinyellow
because it was in relief as for skin surface; on the contrary the
striae alba appeared green/blue because it was depressed as
for skin surface (Figure 3).
Thank to Primos analyses, all volunteers were then di-
vided into three diﬀerent groups in relation to stretch marks
types. The 20% of the volunteers had a striae rubra, the 45%
hadastriaealba,andthe35%hadbothstriarubrathenstriae
alba.
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Figure 3: Striae rubra (yellow) and striae alba(green/blue).
By 22MHz ultrasound imaging, it has been possible to
visualizestretchmarkasapoorechogeniczonelocalizedinto
dermis, as shown in Figure 4.
Unlike the Primos, it has not been possible to distinguish
the stretch marks type with the ulrasound imaging.
3.2. Evaluation of Topical Treatment Eﬃcacy
3.2.1. Ultrasound Scanning. Figure 5 shows images of a
skin after 2 months of treatment with the active product
Figure 5(a) and with the placebo Figure 5(b).
The measurements of skin thickness are performed using
the A-scan mode on all subjects at baseline, after 1 month,
and at the end of the study.
Figure 6 shows a comparison graph of the epidermis-
dermis thickness in zone treated with active, with respectDermatology Research and Practice 5
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Figure 4: B-mode image of skin in which epidermis and dermis are visualized as echo-rich characteristics and striae as echo-low zone inside
the dermis: (a) healthy skin; (b)skin with stretch marks.
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Figure 5: B-mode image of skin after two months of treatment: (a) skin treated with active product in which epidermis and dermis are
visualized as echo-rich characteristics and a new white echo-rich zone appears instead of striae; (b) skin treated with placebo in which striae
are visualized as echo-low zone.
to placebo area. Statistical analysis, obtained for both treat-
ments, did not highlight a statistically signiﬁcant reduction
of the thickness. These results could be explained from the
new white echo-rich zone appearing instead of striae that do
not induce dermis thickness modiﬁcation, at least after two
months of treatment.
3.2.2. Primos Results. Data for skin roughness to all assess-
ment times were obtained by elaborations of 3D images.
Thedata,includingmeanvaluesandstandarddeviations,are
summarized in Table 1.
Statistical analysis of skin roughness demonstrated that
there was a statistically signiﬁcant reduction of Rp parameter
only in the active treated (A) group, and no statistically
signiﬁcant diﬀerences were measured on Rv parameter in
both Pl (placebo) and A (active) group.
In Figure 7 it is clear that, after two months of treatment,
a statistically reduction of Rp value is obtained only in the
active-treated groups.
For two volunteers the instrument was been used also to
determine the total area, total volume, average depth of the
SD of the skin. We selected volunteers with diﬀerent types
of striae in order to evaluate the eﬀective of the treatment
in immature and mature stretch marks. The results are sum-
marized in Table 2.
The Primos system has allowed us to evaluate, by
matching,thesameskinareainthethreesubsequentanalysis
times.Forexample,Figures8(a)and8(b)showstretchmarks
in 3D mode and in color scale and in grey scale images,
obtained at 0 and 2 months time. The images concern the
area treated. Figure 8(a) shows a skin area selected before
treatment: in the image in a color scale it is possible to
visualize the striae rubra that appear as yellow length streaks,
and this is because at the beginning of SD maturation the
striae are in relief. In the same zone it is possible to note
the striae alba in baby-blue/blue color that represent a depth
region of the skin.6 Dermatology Research and Practice
Table 2: Value of total area, total volume, and average depth of the SD of the skin.
Volunteer with striae rubra and alba Volunteer with striae alba
T0 T2 T0 T2
Striae count 32 19 15 11
Average depth of striae 62 µm4 1 µm3 9 µm3 7 µm
Total striae area 144.09mm2 124.49mm2 44.35mm2 43.49mm2
Total striae volume 9.15mm3 5.09mm3 1.72mm3 1.61mm3
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Figure 6: Curve trend of epidermis-dermis thickness in placebo
and active-treated area.
Figure 8(b) shows the same skin area represented after
two months of treatment: in the image in a color scale is
possible to visualize the modiﬁcation of SD wave. After two
months of treatment with active product the skin seems
more homogeneous and the striae rubra appear less deﬁned.
The striae alba in baby-blue/blue color do not appear really
modiﬁed at the end of the treatment.
4. Discussion
The present investigation was carried out on 20 healthy
volunteers to monitor the striae distensae maturation and
to evaluate their modiﬁcation after treatment. Recent or
immature SDs are ﬂattened areas of skin with a pink-red
hue that may be itchy and slightly raised. Stretch marks then
tend to increase in length and acquire a darker purple color.
Over time, they become white, ﬂat, and depressed. Several
treatments have been proposed; yet no consistent modality is
available. Some authors have suggested that time is the only
treatment for SD and that they return to normal over years,
which is not true [2, 3]. The in vivo evaluation of human
skinsurfacetopographyisofgreatinterestfordermatological
research because this type of topography represents the
three-dimensional (3D) organization of the dermis and
the subcutaneous tissue. The surface topography can be
considered a mirror of the functional status of the skin. It
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Figure 7:CurvetrendofRpandRvincontrolandtreatedskinarea.
is an expression of the possibility for the skin to respond
to mechanical stimuli and threats. Various treatments exist
to reverse or at least decrease the skin changes. In order
to assess the success of a stretch marks treatment the
depth, variation, and distribution of the furrows need to be
measured prior and after application of the pharmaceutical
orcosmeticproduct[40].ThePRIMOSisareliableandvalid
objective tool for evaluating surface roughness in normal
appearing skin, in burn scars, in facial acne scars, and in
psoriasis lesion [39, 46, 47]. By means of the PRIMOS, striae
distensae maturation and ﬁnal outcome can be measured
and documented.
By ultrasound imaging, it is possible to visualize and
diagnose the striae that appear in a very diﬀerent way with
respect to other dermis diseases, such as adipose protusions
of the subcutis.
Thehigh-frequencyultrasoundand the3Dimagedevice,
describedinthiswork,canbesuccessfullyemployedtogether
i no r d e rt oe v a l u a t et h ee ﬃcacy of a topical treatment.
The results of this study highlighted that, after two
months oftreatment,the striae rubraseemtobe less deﬁned;
so the skin appears more homogeneous. The striae alba in
baby-blue/bluecolordonotappearreallymodiﬁedattheend
of the treatment.Dermatology Research and Practice 7
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Figure 8: Stretch marks in 3D mode and in color scale and in grey scale images obtained before (a) and after two months of treatment (b).
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Figure 9: Skin analysis in a subject with striae rubra and striae alba before (T0) and after 2 months of treatment (T2).8 Dermatology Research and Practice
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Figure 10: Skin analysis in a subject with striae alba before (T0) and after 2 months of treatment (T2). Again it could maintain that the
treatment of striae alba didnot permit to obtain a reduction of this kind of stretch marks.
These results suggest, according to other authors, that
eﬀective treatment of SD could be instituted during the
active stage; well before that the scarring process is complete
(3, 22), that is, when SDs are identiﬁed like striae rubra.
This was conﬁrmed by statistical analysis of skin roughness
that demonstrated how Rp value subjected a statistically
signiﬁcant reduction only in a treated group. In fact, the
Rp value represents a maximum peak height in the area se-
lected. Instead, Rv value, that represents maximum valley
depth, doesnot subject variation. These results are in agree-
ment with the foregoing results (Figure 7) and they could
demonstrate that after two months, of treatment only the
striae rubra can be treated successfully.
The instrument has been used also to determine the
total area, total volume, and average depth of the SD in
two volunteers in order to support the hypothesis aforesaid.
Figure 9 shows the results obtained at 0 and 2 months in a
volunteer with striae rubra and alba; instead Figure 10 shows
the results obtained at 0 and 2 months in a volunteer with
striae alba.
5. Conclusions
Striae Distensae are a common skin condition that rarely
causes some signiﬁcant medical problems but are often a
signiﬁcant source of distress to those aﬀected.
In summary, this work demonstrated that the PRIMOS
device can measure and document striae distensae type and
maturation.
Furthermore, the high-frequency ultrasound and the 3D
image device, described in this work, can be successfully
employed in order to evaluate the eﬃcacy of a topical
treatment.
In order to deﬁne guidelines for the application of these
techniques in the stretch marks treatment, further studies
enrolling more volunteers are necessary.
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